{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:16:14Z","timestamp":1781237774061,"version":"3.54.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Leukemia and lymphoma are 2 common hematologic cancers in adolescents and young adults (AYAs, age 15-39 years at diagnosis); however, this population has historically had lower clinical trial enrollment and less dramatic improvements in overall survival compared to other age populations. Several unique challenges to delivering care to this population have affected drug development, clinical trial availability, accessibility, and acceptance, all of which impact clinical trial enrollment. Recently, several national and institutional collaborative approaches have been utilized to improve trial availability and accessibility for AYAs with hematologic malignancies. In this review, we discuss the known barriers to cancer clinical trial enrollment and potential approaches and solutions to improve enrollment for AYAs with leukemia and lymphoma on clinical trials.<\/jats:p>","DOI":"10.1182\/hematology.2024000526","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:03:02Z","timestamp":1733497382000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Sharing is caring: a network collaborative approach to identify and address barriers in accessing clinical trials in adolescents and young adults with leukemia and lymphoma"],"prefix":"10.1182","volume":"2024","author":[{"given":"Caroline","family":"Hesko","sequence":"first","affiliation":[{"name":"1 University of Vermont Children's Hospital, Burlington, VT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Heath","sequence":"additional","affiliation":[{"name":"1 University of Vermont Children's Hospital, Burlington, VT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Roth","sequence":"additional","affiliation":[{"name":"2 MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Mittal","sequence":"additional","affiliation":[{"name":"3 Rush University Medical Center, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"1","key":"2024121115401306500_hem2024000526C1","doi-asserted-by":"crossref","first-page":"e27426","DOI":"10.1002\/pbc.27426","article-title":"Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States","volume":"66","author":"Parsons","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"27","key":"2024121115401306500_hem2024000526C2","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"2024121115401306500_hem2024000526C3","doi-asserted-by":"crossref","first-page":"e26421","DOI":"10.1002\/pbc.26421","article-title":"Staging evaluation and response criteria harmonization (SEARCH) for childhood, adolescent and young adult Hodgkin lymphoma (CAYAHL): methodology statement","volume":"64","author":"Flerlage","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2024121115401306500_hem2024000526C4","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3026(21)00349-5","article-title":"Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials","volume":"9","author":"Kahn","year":"2022","journal-title":"Lancet Haematol"},{"issue":"17_suppl","key":"2024121115401306500_hem2024000526C5","doi-asserted-by":"crossref","first-page":"lba4","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA4","article-title":"SWOG S1826, a randomized study of nivolumab (N)-AVD versus brentuximab vedotin (BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL)","volume":"41","author":"Herrera","year":"2023","journal-title":"J Clin Oncol"},{"issue":"14","key":"2024121115401306500_hem2024000526C6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"issue":"17","key":"2024121115401306500_hem2024000526C7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"2024121115401306500_hem2024000526C8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/bloodadvances.2020002439","article-title":"Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia","volume":"5","author":"Advani","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"2024121115401306500_hem2024000526C9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/jha2.787","article-title":"Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma","volume":"4","author":"Toner","year":"2023","journal-title":"EJHaem"},{"key":"2024121115401306500_hem2024000526C10","unstructured":"Pediatric Cancer Studies: early results of the research to accelerate cures and equity for children act. https:\/\/www.gao.gov\/products\/gao-23-105947, January31, 2023."},{"issue":"2","key":"2024121115401306500_hem2024000526C11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40124-015-0075-y","article-title":"The clinical trials gap for adolescents and young adults with cancer: recent progress and conceptual framework for continued research","volume":"3","author":"Freyer","year":"2015","journal-title":"Curr Pediatr Rep"},{"issue":"2","key":"2024121115401306500_hem2024000526C12","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.esmoop.2021.100096","article-title":"Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)","volume":"6","author":"Ferrari","year":"2021","journal-title":"ESMO Open"},{"issue":"1","key":"2024121115401306500_hem2024000526C13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jayao.2013.0011","article-title":"A qualitative study of phase III cancer clinical trial enrollment decision-making: perspectives from adolescents, young adults, caregivers, and providers","volume":"3","author":"Barakat","year":"2014","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"20","key":"2024121115401306500_hem2024000526C14","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1002\/cncr.31727","article-title":"A prospective comparison of cancer clinical trial availability and enrollment among adolescents\/young adults treated at an adult cancer hospital or affiliated children's hospital","volume":"124","author":"Thomas","year":"2018","journal-title":"Cancer"},{"issue":"12","key":"2024121115401306500_hem2024000526C15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/MPH.0b013e3181b91180","article-title":"A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers","volume":"31","author":"Downs-Canner","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"suppl 3","key":"2024121115401306500_hem2024000526C16","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1542\/peds.2014-0122F","article-title":"Improving enrollment in clinical trials for adolescents with cancer","volume":"133","author":"Shaw","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"2024121115401306500_hem2024000526C17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jayao.2019.0125","article-title":"Pediatric physician management as a predictor of clinical trial enrollment in adolescent and young adult cancer patients","volume":"9","author":"Marshall","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"3","key":"2024121115401306500_hem2024000526C18","doi-asserted-by":"crossref","first-page":"pkab027","DOI":"10.1093\/jncics\/pkab027","article-title":"Barriers and facilitators to adolescent and young adult cancer trial enrollment: NCORP site perspectives","volume":"5","author":"Siembida","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"2024121115401306500_hem2024000526C19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/jayao.2019.0139","article-title":"The children's oncology group adolescent and young adult responsible investigator network: a new model for addressing site-level factors impacting clinical trial enrollment","volume":"9","author":"Roth","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"1","key":"2024121115401306500_hem2024000526C20","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1038\/s41598-022-07703-5","article-title":"Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials","volume":"12","author":"Mittal","year":"2022","journal-title":"Sci Rep"},{"key":"2024121115401306500_hem2024000526C21","doi-asserted-by":"crossref","first-page":"101057","DOI":"10.1016\/j.conctc.2023.101057","article-title":"Clinical research coordinators: key components of an efficient clinical trial unit","volume":"32","author":"Mora","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"2024121115401306500_hem2024000526C22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2288-13-154","article-title":"Facilitating accrual to cancer control and supportive care trials: the clinical research associate perspective","volume":"13","author":"Vanhoff","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"2024121115401306500_hem2024000526C23","doi-asserted-by":"crossref","first-page":"e27991","DOI":"10.1002\/pbc.27991","article-title":"Models of care for adolescent and young adult cancer programs","volume":"66","author":"Osborn","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"2024121115401306500_hem2024000526C24","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.1200\/OP.22.00063","article-title":"Guidance to support the implementation of specialized adolescent and young adult cancer care: a qualitative analysis of cancer programs","volume":"18","author":"Haines","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"2024121115401306500_hem2024000526C25","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.33399","article-title":"Use of a clinical trial screening tool to enhance patient accrual","volume":"127","author":"St Germain","year":"2021","journal-title":"Cancer"},{"issue":"14","key":"2024121115401306500_hem2024000526C26","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1002\/cncr.26634","article-title":"Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions","volume":"118","author":"Shaw","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"2024121115401306500_hem2024000526C27","doi-asserted-by":"crossref","first-page":"100898","DOI":"10.1016\/j.currproblcancer.2022.100898","article-title":"Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)","volume":"47","author":"Hesko","year":"2023","journal-title":"Curr Probl Cancer"},{"issue":"21","key":"2024121115401306500_hem2024000526C28","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1002\/cncr.34402","article-title":"Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network","volume":"128","author":"Sankaran","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"2024121115401306500_hem2024000526C29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/asheducation-2018.1.154","article-title":"Adolescent angst: enrollment on clinical trials","volume":"2018","author":"Keegan","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"2024121115401306500_hem2024000526C30","doi-asserted-by":"crossref","first-page":"pkz057","DOI":"10.1093\/jncics\/pkz057","article-title":"Access to clinical trials for adolescents and young adults with cancer: a meta-research analysis","volume":"3","author":"de Rojas","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"2024121115401306500_hem2024000526C31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/jayao.2021.0041","article-title":"Barriers to pediatric oncologist enrollment of adolescents and young adults on a cross-network National Clinical Trials Network supportive care cancer clinical trial","volume":"11","author":"Mittal","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"10","key":"2024121115401306500_hem2024000526C32","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1200\/JOP.19.00707","article-title":"Understanding the barriers to pediatric oncologist engagement and accrual to clinical trials in National Cancer Institute-designated community oncology research programs","volume":"16","author":"Dickens","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2024121115401306500_hem2024000526C33","doi-asserted-by":"crossref","DOI":"10.1177\/10732748221130164","article-title":"Addressing the barriers to clinical trials accrual in community cancer centres using a national clinical trials navigator: a cross-sectional analysis","volume":"29","author":"Hamm","year":"2022","journal-title":"Cancer Control"},{"issue":"5","key":"2024121115401306500_hem2024000526C34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","article-title":"Increasing diversity in clinical trials: overcoming critical barriers","volume":"44","author":"Clark","year":"2019","journal-title":"Curr Probl Cardiol"},{"issue":"2","key":"2024121115401306500_hem2024000526C35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jayao.2021.0026","article-title":"Systems-level change to alleviate barriers to cancer clinical trial access for adolescents and young adults in Australia","volume":"11","author":"Ellis","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"suppl 13","key":"2024121115401306500_hem2024000526C36","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cncr.34206","article-title":"The American Cancer Society and patient navigation: past and future perspectives","volume":"128","author":"Knudsen","year":"2022","journal-title":"Cancer"},{"issue":"11","key":"2024121115401306500_hem2024000526C37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JOP.19.00230","article-title":"Patient navigation in cancer: the business case to support clinical needs","volume":"15","author":"Kline","year":"2019","journal-title":"J Oncol Pract"},{"issue":"5","key":"2024121115401306500_hem2024000526C38","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/curroncol31050193","article-title":"The development and impact of AYA Can\u2014Canadian cancer advocacy: a peer-led advocacy organization for adolescent and young adult cancer in Canada","volume":"31","author":"Thurston","year":"2024","journal-title":"Curr Oncol"},{"issue":"9","key":"2024121115401306500_hem2024000526C39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.21037\/atm.2018.04.46","article-title":"Transforming research: engaging patient advocates at all stages of cancer research","volume":"6","author":"Ciccarella","year":"2018","journal-title":"Ann Transl Med"},{"key":"2024121115401306500_hem2024000526C40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000506840","article-title":"A retrospective analysis of clinical trial accrual of patients presented in a multidisciplinary tumor board at a tertiary health care center and associated barriers","volume":"43","author":"Mobley","year":"2020","journal-title":"Oncol Res Treat"},{"key":"2024121115401306500_hem2024000526C41","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1200\/OP.19.00325","article-title":"Improving the time to activation of new clinical trials at a National Cancer Institute-designated comprehensive cancer center","volume":"16","author":"Williams","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2024121115401306500_hem2024000526C42","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1200\/JOP.19.00662","article-title":"Barriers to participation in therapeutic clinical trials as perceived by community oncologists","volume":"16","author":"Wong","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2024121115401306500_hem2024000526C43","doi-asserted-by":"crossref","first-page":"e38514","DOI":"10.2196\/38514","article-title":"Creating and implementing a principal investigator tool kit for enhancing accrual to late phase clinical trials: development and usability study","volume":"8","author":"Higgins","year":"2022","journal-title":"JMIR Cancer"},{"key":"2024121115401306500_hem2024000526C44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/ajco.13899","article-title":"Telehealth adoption in cancer clinical trials: an Australian perspective","volume":"19","author":"Thomas","year":"2023","journal-title":"Asia Pac J Clin Oncol"},{"key":"2024121115401306500_hem2024000526C45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1200\/OP.21.00554","article-title":"Use of communication technology to improve clinical trial participation in adolescents and young adults with cancer: Consensus statement from the Children\u2019s Oncology Group Adolescent and Young Adult Responsible Investigator Network","volume":"18","author":"Avutu","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"2024121115401306500_hem2024000526C46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13063-018-3097-2","article-title":"Effectiveness of a short video- based educational intervention on factors related to clinical trial participation in adolescents and young adults: a pre-test\/post-test design","volume":"20","author":"Cowdery","year":"2019","journal-title":"Trials"},{"key":"2024121115401306500_hem2024000526C47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13187-017-1294-4","article-title":"Age- specific patient navigation preferences among adolescents and young adults with cancer","volume":"34","author":"Pannier","year":"2019","journal-title":"J Cancer Educ"},{"key":"2024121115401306500_hem2024000526C48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/OP.23.00328","article-title":"Characteristics of health care settings where adolescents and young adults receive care for ALL","volume":"20","author":"Wolfson","year":"2024","journal-title":"JCO Oncol Pract"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/27\/2346359\/27hesko.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/27\/2346359\/27hesko.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T19:58:40Z","timestamp":1733947120000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2024\/1\/27\/526149\/Sharing-is-caring-a-network-collaborative-approach"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2024000526","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,6]]},"published":{"date-parts":[[2024,12,6]]}}}